drugset
drugset / Trial / NCT03988803

A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other

NCT03988803 ↗

Phase 1 Completed 16 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Investigate the effect of steady state exposures of memantine on the steady-state pharmacokinetics of BI 425809 and vice versa in healthy subjects.

Timeline

Start
2019-07-17
Primary completion
2019-10-30
Completion
2019-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Iclepertin Small molecule — —
Subject Memantine Unknown — —

Indications

No indication recorded.